BRCA2 KO Lines for Drug Discovery

BRACA2 is a DNA repair gene. Mutations in BRACA2 cause an inherited risk of breast, ovarian and pancreatic cancers. The cancer cell lines are engineered to lack BRACA2 and are useful screening tools for chemotherapeutic or chemopreventative agents Description (Set) Proposed Use (Set) The BRACA2 KO cell line is a useful screening tools for chemotherapeutic or chemopreventative agents.

Inventor(s): Kern, Scott

Type of Offer: Licensing



« More Medical Patents

---